Level of evidence: Randomised, double-blind, placebo-controlled trial
Intravenous dexmedetomidine given to patients over 65 in the first 24 hours who are admitted to ITU following a major surgery can significantly reduce the risk of delirium (9% vs 23%, P<0⋅0001)
Lancet 2016; 388: 1893–1902.